NewAmsterdam Pharma Co N.V. Quarterly Liabilities and Equity in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
NewAmsterdam Pharma Co N.V. quarterly Liabilities and Equity history and growth rate from Q4 2022 to Q3 2024.
  • NewAmsterdam Pharma Co N.V. Liabilities and Equity for the quarter ending September 30, 2024 was $439M.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $439M Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $447M Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $488M Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $347M -$131M -27.5% Dec 31, 2023 10-Q 2024-11-06
Q4 2022 $478M Dec 31, 2022 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.